Tesla is working on new battery cell designs, and a way to make their own cells, with R&D teams in a lab near its car plant in Fremont, California.Technologyread more
The Federal Reserve and the market are miles apart on interest rate expectations, and the disparity could cost the stock market a 7%-10% drop, economists say.Economyread more
President Trump lambastes Twitter, Google and other technology giants for what he claims as their efforts to stifle him.US Economyread more
Underneath the impressive market rally is a trend that doesn't seem quite right, according to J.P. Morgan.Marketsread more
The shutdown of the fire-damaged Philadelphia Energy Solutions refining complex could send gasoline prices higher across the U.S., but particularly in the mid-Atlantic region...Market Insiderread more
Mnuchin tells CNBC he's confident President Trump and China's Xi Jinping can make progress in stalled trade talks.World Economyread more
Bitcoin topped the $13,000 level Wednesday, rallying to its highest price since January 2018.Bitcoinread more
JP Morgan's Jamie Dimon says student lending "is a disgrace and it's hurting America."Economyread more
During the foreclosure crisis, investors transformed the single-family home rental market into a formally managed asset class. Now they want new homes.Real Estateread more
Wayfair drew backlash and calls from some customers for a boycott after employees protested the company's apparent sale of $200,000 of mattresses and bunk beds destined for a...Retailread more
These are the stocks posting the largest moves midday.Market Insiderread more
It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Brightcove: "Brightcove I think is a little risky. It's making a lot of money there and the stock has had a very big run. My take is don't buy, don't buy."
Sarepta Therapautics: "This is one of the highest risk stocks in the world. It's a binary stock; they either get approval or they don't. If they get approval, the stock has still doubled from $28. And if they don't get approval the stock can get crushed. I think it's way too risky for me."
Marathon Oil: "It's worked its way all the way back. I've got to hand it to them, but I've got to tell you we've got a couple of winners that I like more. We've got Pioneer and EOG if you want to be a little bit more speculative, and we've got Occidental which my charitable trust owns."
Ford: "I think you'll do fine in Ford. It's got a good yield, it's got a good balance sheet. The sales are just OK. The Chinese sales were quite impressive that were announced the other day, but I don't think the stock can run away."
Cliffs Natural Resources: "I think it's a little risky because it's had a run back. I know that a lot of people like Tech Resources, BHP and Rio. Those stocks were strong today, but Cliffs at $6? I don't know. A lot of things have to go right. I wouldn't sell it, but I certainly wouldn't buy anymore."